Gut Microbiome in People Living With HIV and HBV
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorKangbuk Samsung Hospital
About this trial
Building a Microbiome Data Platform and Conducting Clinical Evidence Research in Individuals Infected with the Human Immunodeficiency Virus (HIV) and Hepatitis B virus.
Eligibility criteria
Qualifiers
HIV patients
Inidividuals over 19 years old
HIV patients on antiretroviral therapy (ART)
HBV patients
Disqualifiers
Patients with indeterminate colitis
Individuals who have used antibiotics or steroids within 24 hours of the microbiome sample collection (excluding antiviral treatments for hepatitis B and HIV)
Individuals who have used vaginal or external medications, including antifungal agents, within 24 hours of microbiome sample collection
Those with acute illnesses, with or without fever, of moderate or severe severity; however, sampling may be postponed until the subject recovers.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 2 trial groupsLocations
Sponsors and collaborators
Kangbuk Samsung Hospital
Lead sponsor
Kyunghee University Medical Center
Collaborator
Hanyang University
Collaborator
Source ClinicalTrials.gov